Regarding grade II astrocytoma, the ITGA2 genotype (+/+ and +/-) exhibited higher frequency and, in contrast, increased median survival compared to the homozygous -/- genotype. This evidence concerns the gene ITGA2 and astrocytoma (excluding glioblastoma).